Straumann Holding AG Receivables 2012-2021 | SAUHY
Straumann Holding AG receivables from 2012 to 2021. Receivables can be defined as the total amount of collectibles for a company
- Straumann Holding AG receivables for the quarter ending December 31, 2021 were $0.434B, a 39.99% increase year-over-year.
- Straumann Holding AG receivables for 2021 were $0.434B, a 34.21% increase from 2020.
- Straumann Holding AG receivables for 2020 were $0.323B, a 16.62% decline from 2019.
- Straumann Holding AG receivables for 2019 were $0.388B, a 25.09% increase from 2018.
Straumann Holding AG Annual Receivables
(Millions of US $) |
| 2021 |
$434 |
| 2020 |
$323 |
| 2019 |
$388 |
| 2018 |
$310 |
| 2017 |
$252 |
| 2016 |
$193 |
| 2015 |
$156 |
| 2014 |
$144 |
| 2013 |
$123 |
| 2012 |
$111 |
| 2011 |
$126 |
Straumann Holding AG Quarterly Receivables
(Millions of US $) |
| 2021-12-31 |
$434 |
| 2020-12-31 |
$323 |
| 2020-06-30 |
$335 |
| 2019-12-31 |
$388 |
| 2018-12-31 |
$310 |
| 2017-12-31 |
$252 |
| 2017-06-30 |
$241 |
| 2016-12-31 |
$193 |
| 2016-06-30 |
$203 |
| 2015-12-31 |
$156 |
| 2014-12-31 |
$144 |
| 2013-12-31 |
$123 |
| 2013-06-30 |
$141 |
| 2012-12-31 |
$111 |
| 2012-06-30 |
$144 |
| 2011-12-31 |
$126 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$23.137B |
$2.685B |
|
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
|
